236 related articles for article (PubMed ID: 25609598)
1. Proteomic enrichment analysis of psychotic and affective disorders reveals common signatures in presynaptic glutamatergic signaling and energy metabolism.
Gottschalk MG; Wesseling H; Guest PC; Bahn S
Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25609598
[TBL] [Abstract][Full Text] [Related]
2. Targeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disorders.
Wesseling H; Gottschalk MG; Bahn S
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539505
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics.
Matosin N; Fernandez-Enright F; Frank E; Deng C; Wong J; Huang XF; Newell KA
J Psychiatry Neurosci; 2014 Nov; 39(6):407-16. PubMed ID: 24949866
[TBL] [Abstract][Full Text] [Related]
4. Serum kynurenic acid is reduced in affective psychosis.
Wurfel BE; Drevets WC; Bliss SA; McMillin JR; Suzuki H; Ford BN; Morris HM; Teague TK; Dantzer R; Savitz JB
Transl Psychiatry; 2017 May; 7(5):e1115. PubMed ID: 28463241
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Proteomic Measures Across Serious Psychiatric Illness.
Schulz SC; Overgaard S; Bond DJ; Kaldate R
Clin Schizophr Relat Psychoses; 2017; 11(2):103-112. PubMed ID: 28742394
[TBL] [Abstract][Full Text] [Related]
6. Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients.
Martins-de-Souza D; Guest PC; Harris LW; Vanattou-Saifoudine N; Webster MJ; Rahmoune H; Bahn S
Transl Psychiatry; 2012 Mar; 2(3):e87. PubMed ID: 22832852
[TBL] [Abstract][Full Text] [Related]
7. Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathology.
Cox DA; Gottschalk MG; Wesseling H; Ernst A; Cooper JD; Bahn S
Schizophr Res; 2016 Nov; 177(1-3):98-107. PubMed ID: 27335180
[TBL] [Abstract][Full Text] [Related]
8. Post-mortem molecular profiling of three psychiatric disorders.
Ramaker RC; Bowling KM; Lasseigne BN; Hagenauer MH; Hardigan AA; Davis NS; Gertz J; Cartagena PM; Walsh DM; Vawter MP; Jones EG; Schatzberg AF; Barchas JD; Watson SJ; Bunney BG; Akil H; Bunney WE; Li JZ; Cooper SJ; Myers RM
Genome Med; 2017 Jul; 9(1):72. PubMed ID: 28754123
[TBL] [Abstract][Full Text] [Related]
9. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
[TBL] [Abstract][Full Text] [Related]
10. The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.
Lavebratt C; Olsson S; Backlund L; Frisén L; Sellgren C; Priebe L; Nikamo P; Träskman-Bendz L; Cichon S; Vawter MP; Osby U; Engberg G; Landén M; Erhardt S; Schalling M
Mol Psychiatry; 2014 Mar; 19(3):334-41. PubMed ID: 23459468
[TBL] [Abstract][Full Text] [Related]
11. Family Genetic Risk Scores and the Genetic Architecture of Major Affective and Psychotic Disorders in a Swedish National Sample.
Kendler KS; Ohlsson H; Sundquist J; Sundquist K
JAMA Psychiatry; 2021 Jul; 78(7):735-743. PubMed ID: 33881469
[TBL] [Abstract][Full Text] [Related]
12. Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients.
Chan MK; Tsang TM; Harris LW; Guest PC; Holmes E; Bahn S
Mol Psychiatry; 2011 Dec; 16(12):1189-202. PubMed ID: 20921955
[TBL] [Abstract][Full Text] [Related]
13. In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder.
Pearlson GD; Wong DF; Tune LE; Ross CA; Chase GA; Links JM; Dannals RF; Wilson AA; Ravert HT; Wagner HN
Arch Gen Psychiatry; 1995 Jun; 52(6):471-7. PubMed ID: 7771917
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal Proteomic and Metabonomic Abnormalities in Neurotransmission, Oxidative Stress, and Apoptotic Pathways in a Chronic Phencyclidine Rat Model.
Wesseling H; Want EJ; Guest PC; Rahmoune H; Holmes E; Bahn S
J Proteome Res; 2015 Aug; 14(8):3174-87. PubMed ID: 26043028
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
Behan AT; Byrne C; Dunn MJ; Cagney G; Cotter DR
Mol Psychiatry; 2009 Jun; 14(6):601-13. PubMed ID: 18268500
[TBL] [Abstract][Full Text] [Related]
16. The utility of SELENBP1 gene expression as a biomarker for major psychotic disorders: replication in schizophrenia and extension to bipolar disorder with psychosis.
Kanazawa T; Chana G; Glatt SJ; Mizuno H; Masliah E; Yoneda H; Tsuang MT; Everall IP
Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):686-9. PubMed ID: 18163446
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological and clinical characterization following a first psychotic episode in major depressive disorder: comparisons with schizophrenia and bipolar I disorder in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).
Owoeye O; Kingston T; Scully PJ; Baldwin P; Browne D; Kinsella A; Russell V; O'Callaghan E; Waddington JL
Schizophr Bull; 2013 Jul; 39(4):756-65. PubMed ID: 23716714
[TBL] [Abstract][Full Text] [Related]
18. Post-mortem evidence from human brain tissue of disturbed glucose metabolism in mood and psychotic disorders.
Regenold WT; Phatak P; Kling MA; Hauser P
Mol Psychiatry; 2004 Aug; 9(8):731-3. PubMed ID: 15098005
[No Abstract] [Full Text] [Related]
19. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
Goldsmith DR; Rapaport MH; Miller BJ
Mol Psychiatry; 2016 Dec; 21(12):1696-1709. PubMed ID: 26903267
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate metabolism in brain disease. II. Glucose metabolism in Schizophrenic, manic-depressive, and involutional psychoses.
HENNEMAN DH; ALTSCHULE MD; GONCZ RM
AMA Arch Intern Med; 1954 Sep; 94(3):402-16. PubMed ID: 13196721
[No Abstract] [Full Text] [Related]
[Next] [New Search]
